Perception of the treatment vaccines for COVID-19 (Coronavirus disease-2019) - Review on current status

S. Surapaneni
{"title":"Perception of the treatment vaccines for COVID-19 (Coronavirus disease-2019) - Review on current status","authors":"S. Surapaneni","doi":"10.13040/IJPSR.0975-8232.12(9).4676-83","DOIUrl":null,"url":null,"abstract":"A Novel virus, coronavirus 2 (SARS-CoV-2), in 2019 from Wuhan, China which is globally expanded, causing the severe acute respiratory syndrome. Coronavirus is transmitted human to animal or human to human through airborne droplets. Coronavirus causes respiratory infections like pneumonia, cold, sneezing and coughing, while in animals, it causes diarrhoea and upper respiratory diseases. The virus outbreak has been declared a public health emergency of international concern by the World Health Organization (WHO), Since Covid -19 rapidly spread throughout the world from the Hunan seafood market at Wuhan, South China. The virus enters into the human cell through the membrane ACE-2 exopeptidase receptor. WHO and ECDC guided to stay away from a public place and close contact with contaminated individuals and pets. Coronavirus (2019-CoV), first and foremost, was isolated on 7th January 2020 at Wuhan market China. Here we have encapsulated the current clinical features data to guide budding Covid-19 about the Prevention, Diagnosis, Treatments and Prevention. Throughout the world, the disease has caused a range of degrees of sickness. The patient manifests various symptoms, usually Fever, Cough, Sore throat, Breathlessness, Fatigue. We collected the data from various, articles Research Report, and WHO guidelines in this review. It is necessary to give awareness to the readers that new data is updating nearly every hour regarding clinical characteristics, diagnosis, treatment strategies, and outcomes COVID-19. The disease is being treated through general treatment, symptomatic treatment, using some antiviral drugs, oxygen therapy and altering the immune system. WHO declared the SARS-Cov-2 virus in March 2020 as a global pandemic. It is necessary to identify the major causes and detach the suspected people from the confirmed cases of COVID-19 to prevent the possible transmission of infection to other patients and health care staff. It will be possible to assess this global disaster's full health, social and economic impact only when the pandemic ends. This review represents a picture of the current state of the treatment for Covid-19.","PeriodicalId":90866,"journal":{"name":"International journal of pharmaceutical sciences and research","volume":"22 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of pharmaceutical sciences and research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.13040/IJPSR.0975-8232.12(9).4676-83","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

A Novel virus, coronavirus 2 (SARS-CoV-2), in 2019 from Wuhan, China which is globally expanded, causing the severe acute respiratory syndrome. Coronavirus is transmitted human to animal or human to human through airborne droplets. Coronavirus causes respiratory infections like pneumonia, cold, sneezing and coughing, while in animals, it causes diarrhoea and upper respiratory diseases. The virus outbreak has been declared a public health emergency of international concern by the World Health Organization (WHO), Since Covid -19 rapidly spread throughout the world from the Hunan seafood market at Wuhan, South China. The virus enters into the human cell through the membrane ACE-2 exopeptidase receptor. WHO and ECDC guided to stay away from a public place and close contact with contaminated individuals and pets. Coronavirus (2019-CoV), first and foremost, was isolated on 7th January 2020 at Wuhan market China. Here we have encapsulated the current clinical features data to guide budding Covid-19 about the Prevention, Diagnosis, Treatments and Prevention. Throughout the world, the disease has caused a range of degrees of sickness. The patient manifests various symptoms, usually Fever, Cough, Sore throat, Breathlessness, Fatigue. We collected the data from various, articles Research Report, and WHO guidelines in this review. It is necessary to give awareness to the readers that new data is updating nearly every hour regarding clinical characteristics, diagnosis, treatment strategies, and outcomes COVID-19. The disease is being treated through general treatment, symptomatic treatment, using some antiviral drugs, oxygen therapy and altering the immune system. WHO declared the SARS-Cov-2 virus in March 2020 as a global pandemic. It is necessary to identify the major causes and detach the suspected people from the confirmed cases of COVID-19 to prevent the possible transmission of infection to other patients and health care staff. It will be possible to assess this global disaster's full health, social and economic impact only when the pandemic ends. This review represents a picture of the current state of the treatment for Covid-19.
对COVID-19(冠状病毒病-2019)治疗疫苗的认识-现状综述
一种新型病毒,冠状病毒2 (SARS-CoV-2),于2019年从中国武汉传播到全球,导致严重急性呼吸系统综合征。冠状病毒通过空气飞沫在人与动物或人与人之间传播。冠状病毒会导致肺炎、感冒、打喷嚏和咳嗽等呼吸道感染,而在动物中,它会导致腹泻和上呼吸道疾病。随着新型冠状病毒感染症(Covid -19)从中国南方武汉的湖南海鲜市场迅速蔓延到世界各地,世界卫生组织(WHO)已将该病毒宣布为国际关注的突发公共卫生事件。病毒通过细胞膜ACE-2外肽酶受体进入人体细胞。世卫组织和疾控中心指导人们远离公共场所,并与受感染的个人和宠物密切接触。冠状病毒(2019-CoV)首先于2020年1月7日在中国武汉市场被分离出来。在这里,我们总结了当前的临床特征数据,以指导新冠肺炎的预防、诊断、治疗和预防。在世界范围内,这种疾病引起了不同程度的疾病。病人表现出各种症状,通常是发烧、咳嗽、喉咙痛、呼吸困难、疲劳。我们从各种文章、研究报告和世卫组织指南中收集数据。有必要让读者意识到,关于COVID-19的临床特征、诊断、治疗策略和结果的新数据几乎每小时都在更新。这种疾病正在通过一般治疗、对症治疗、使用一些抗病毒药物、氧气治疗和改变免疫系统来治疗。世卫组织于2020年3月宣布SARS-Cov-2病毒为全球大流行。有必要查明主要原因,并将疑似病例与确诊病例隔离开来,防止可能的感染传播给其他患者和医护人员。只有在疫情结束后,才有可能评估这场全球灾难对健康、社会和经济的全面影响。本综述概述了Covid-19治疗的现状。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信